Arcus Biosciences, Inc.
RCUS
$22.43
$0.220.99%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 981.00M | 831.00M | 911.00M | 997.00M | 978.00M |
| Total Receivables | 16.00M | 14.00M | 20.00M | 21.00M | 25.00M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 10.00M | 12.00M | 15.00M | 13.00M | 13.00M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1.01B | 857.00M | 946.00M | 1.03B | 1.02B |
|
|
|||||
| Total Current Assets | 1.01B | 857.00M | 946.00M | 1.03B | 1.02B |
| Net Property, Plant & Equipment | 98.00M | 42.00M | 44.00M | 46.00M | 112.00M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 5.00M | 65.00M | 69.00M | 71.00M | 8.00M |
| Total Assets | 1.14B | 974.00M | 1.08B | 1.16B | 1.15B |
|
|
|||||
| Total Accounts Payable | 42.00M | 42.00M | 29.00M | 22.00M | 18.00M |
| Total Accrued Expenses | 122.00M | 112.00M | 82.00M | 69.00M | 96.00M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 13.00M | 13.00M | 12.00M | 12.00M | 12.00M |
| Total Finance Division Other Current Liabilities | 54.00M | 68.00M | 87.00M | 89.00M | 100.00M |
| Total Other Current Liabilities | 54.00M | 68.00M | 87.00M | 89.00M | 100.00M |
| Total Current Liabilities | 231.00M | 235.00M | 210.00M | 192.00M | 226.00M |
|
|
|||||
| Total Current Liabilities | 231.00M | 235.00M | 210.00M | 192.00M | 226.00M |
| Long-Term Debt | 120.00M | 119.00M | 118.00M | 69.00M | 69.00M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 86.00M | -- | -- | -- | 99.00M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 71.00M | 184.00M | 198.00M | 364.00M | 271.00M |
| Total Liabilities | 508.00M | 538.00M | 526.00M | 625.00M | 665.00M |
|
|
|||||
| Common Stock & APIC | 2.12B | 1.82B | 1.79B | 1.78B | 1.62B |
| Retained Earnings | -1.49B | -1.38B | -1.24B | -1.24B | -1.13B |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 631.00M | 436.00M | 549.00M | 531.00M | 485.00M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 631.00M | 436.00M | 549.00M | 531.00M | 485.00M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 631.00M | 436.00M | 549.00M | 531.00M | 485.00M |
|
|
|||||